231 related articles for article (PubMed ID: 4405377)
1. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
Bekes M; Matos L; Rausch J; Török E
Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
[No Abstract] [Full Text] [Related]
2. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
Békés M; Matos L; Rausch J; Török E
Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774
[No Abstract] [Full Text] [Related]
3. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
[No Abstract] [Full Text] [Related]
4. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
5. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
Kubota M; Gotho Y; Furukawa K
Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
[No Abstract] [Full Text] [Related]
6. Cardiac effects of beta-adrenergic receptor antagonists.
Ablad B; Carlsson B; Carlsson E; Dahlöf C; Ek L; Hultberg E
Adv Cardiol; 1974; 12(0):290-302. PubMed ID: 4151859
[No Abstract] [Full Text] [Related]
7. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
8. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
Takeda K; Iizuka H; Imai S
Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
[No Abstract] [Full Text] [Related]
9. Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
Hague MA; Darabi MK; Khalighi MR
Pahlavi Med J; 1977 Jul; 8(3):326-44. PubMed ID: 21372
[TBL] [Abstract][Full Text] [Related]
10. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
Kulig A; Kostka-Trabka E; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
[No Abstract] [Full Text] [Related]
11. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Gibson DG
Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
[No Abstract] [Full Text] [Related]
12. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
[No Abstract] [Full Text] [Related]
13. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
Madan BR; Gupta RS; Jain BK
Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
[No Abstract] [Full Text] [Related]
14. [Beta adrenergic drugs in arterial hypertension].
Gysling E
Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
[No Abstract] [Full Text] [Related]
15. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.
Day MD; Roach AG
Clin Exp Pharmacol Physiol; 1974; 1(4):333-9. PubMed ID: 4156505
[No Abstract] [Full Text] [Related]
16. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
Levy JV
J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
[No Abstract] [Full Text] [Related]
17. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
Somani P; Laddu AR; Hardm HF
J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
[No Abstract] [Full Text] [Related]
18. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
Kleinrok Z; Ksiazek A
Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
[TBL] [Abstract][Full Text] [Related]
19. Selective beta adrenergic receptor antagonism in the anesthetized dog.
Wasserman MA; Levy B
J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
[No Abstract] [Full Text] [Related]
20. Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
Górka Z
Acta Med Pol; 1973; 14(1):7-26. PubMed ID: 4144422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
